华昊中天医药-B(02563)

4.410+0.0000.00%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
华昊中天医药-B
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.biostar-pharm.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
北京华昊中天生物医药股份有限公司是一家主要从事创新药研发、生产及销售的中国公司。该公司的产品及管线主要包括优替德隆注射液、优替德隆胶囊、优替德隆纳米剂型、优替德隆抗体偶联药物（ADC）、BG22、BG18和BG44。该公司的产品主要用于治疗复发或转移性乳腺癌、人类表皮生长因子受体2（HER2）阴性乳腺癌新辅助治疗、晚期非小细胞肺癌（NSCLC）、实体瘤、乳腺癌脑转移、肺癌脑转移等脑部肿瘤适应症。该公司主要在国内市场开展业务。
- 04-25
  重组
  董事会决议公告
  董事会决议公告
- 02-25
  业绩预告
  盈利预告 - 预期亏损减少
  盈利预告 - 预期亏损减少
- 2024-10-23
  股份发售
  全球发售
  全球发售

分时
5日
日
周
月

数据加载中...

最高

4.410

今开

4.410

量比

1.07

最低

4.410

昨收

4.410

换手率

0.00%

热议股票

{"pagemeta":{"title":"华昊中天医药-B(02563)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华昊中天医药-B(02563)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华昊中天医药-B,02563,华昊中天医药-B股票,华昊中天医药-B股票老虎,华昊中天医药-B股票老虎国际,华昊中天医药-B行情,华昊中天医药-B股票行情,华昊中天医药-B股价,华昊中天医药-B股市,华昊中天医药-B股票价格,华昊中天医药-B股票交易,华昊中天医药-B股票购买,华昊中天医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华昊中天医药-B(02563)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华昊中天医药-B(02563)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"02563","data":{"stockData":{"symbol":"02563","market":"HK","secType":"STK","nameCN":"华昊中天医药-B","latestPrice":4.41,"timestamp":1748827264560,"preClose":4.41,"halted":3,"volume":0,"delay":0,"floatShares":216720857,"shares":364588000,"eps":-0.5895626551199384,"marketStatus":"停牌","change":0,"latestTime":"06-02 09:21:04","open":4.41,"high":4.41,"low":4.41,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.5895626551199384,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1748914200000},"marketStatusCode":0,"adr":0,"listingDate":1730304000000,"exchange":"SEHK","adjPreClose":4.41,"openAndCloseTimeList":[[1748827800000,1748836800000],[1748840400000,1748851200000]],"volumeRatio":1.0694108154509598,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"19511257","market":"hk","labels":[],"media":"港交所","original_id":"N.HK3f5NFydXdw","pdf_url":"https://static.tigerbbs.com/3ec005c052fe4841998bbad9bd056f2a","pub_time":1745593020000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"董事会决议公告","symbol":"02563","title":"董事会决议公告","titleType":"重组","type":"hkAnnouncement","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0425/2025042504300_c.pdf","us_notice_code":"公告及通告 - [内幕消息 / 资本重组 / 修订宪章文件 / 在股东批准的情况下重选或委任董事 / 更换核数师 / 在股...更多]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易披露","type_name_en":"Announcement","titleTypeEn":"Merger And Reorganization","event_type":"important_notice","event_name":"重组","pubTime":"2025-04-25 22:57","pubTimestamp":1745593020,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19164171","market":"hk","labels":[],"media":"港交所","original_id":"N.HKCwWMPU5xcc","pdf_url":"https://static.tigerbbs.com/429faf0d80684dcabbf51c59ffb88214","pub_time":1740490260000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"盈利预告 - 预期亏损减少","symbol":"02563","title":"盈利预告 - 预期亏损减少","titleType":"业绩预告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0225/2025022501070_c.pdf","us_notice_code":"公告及通告 - [盈利警告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Earnings Estimation","event_type":"important_notice","event_name":"业绩预告","pubTime":"2025-02-25 21:31","pubTimestamp":1740490260,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18729230","market":"hk","labels":[],"media":"港交所","original_id":"N.HK6Gb4eMToxW","pdf_url":"https://static.tigerbbs.com/91782eaecce54af7b67e546caa594baa","pub_time":1729635960000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"全球发售","symbol":"02563","title":"全球发售","titleType":"股份发售","type":"hkIPO","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/1023/2024102300016_c.pdf","us_notice_code":"上市文件 - [发售以供认购]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"上市文件","type_name_en":"Listing Document","titleTypeEn":"Shares Subscription","event_type":"important_notice","event_name":"股份发售","pubTime":"2024-10-23 06:26","pubTimestamp":1729635960,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.biostar-pharm.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.7254},{"period":"6month","weight":-0.849},{"period":"1year","weight":-0.7244},{"period":"ytd","weight":-0.7761}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":0.029},{"period":"3month","weight":0.0094},{"period":"6month","weight":0.173},{"period":"1year","weight":0.2809},{"period":"ytd","weight":0.1544}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京华昊中天生物医药股份有限公司是一家主要从事创新药研发、生产及销售的中国公司。该公司的产品及管线主要包括优替德隆注射液、优替德隆胶囊、优替德隆纳米剂型、优替德隆抗体偶联药物（ADC）、BG22、BG18和BG44。该公司的产品主要用于治疗复发或转移性乳腺癌、人类表皮生长因子受体2（HER2）阴性乳腺癌新辅助治疗、晚期非小细胞肺癌（NSCLC）、实体瘤、乳腺癌脑转移、肺癌脑转移等脑部肿瘤适应症。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"华昊中天医药-B","nameEN":"BIOSTAR PHARM-B"},"aProfile":null}}}